ARYx Therapeutics, Inc. (ARYX) has 14 open-market insider trades by 13 insiders since 2007. The most active filer is Nicholas J. Simon III, Director & 10%.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 10% | — | 1 | $8.0M | 2009-05-22 |
| Nicholas J. Simon III | Dir10% | — | 2 | $6.9M | 2008-11-14 |
| Nicholas Galakatos | 10% | — | 1 | $3.9M | 2008-11-14 |
| Bioventures Iii Qp Lp Mpm | 10% | — | 1 | $3.9M | 2008-11-14 |
| Samuel D. Isaly | Dir | — | 1 | $3.0M | 2007-11-13 |
| Robert J. Adelman | Dir10% | — | 1 | $3.0M | 2007-11-13 |
| Dennis Henner | 10% | — | 1 | $3.0M | 2007-11-13 |
| Bioventures Iii Gmbh & Co. Beteiligungs Kg Mpm | 10% | — | 1 | $3.0M | 2007-11-13 |
| C. Richard Kramlich | 10% | — | 1 | $313K | 2011-03-10 |
| Krishna Kittu Kolluri | 10% | — | 1 | $313K | 2011-03-10 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Ryan D. Drant | 10% | Sell | $313K | 2011-03-10 |
| Orbimed Advisors LLC | 10% | Sell | $8.0M | 2009-05-22 |
| Bioventures Iii Qp Lp Mpm | 10% | Buy | $3.9M | 2008-11-14 |
| Nicholas J. Simon III | Director & 10% | Buy | $3.0M | 2007-11-13 |
Companies that share insiders with ARYX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.